Next Article in Journal
Special Issue “Latest Review Papers in Molecular Oncology 2024”
Previous Article in Journal
Multi-Level Profiling of MAPK-Associated Genes and MicroRNAs Uncovers Regulatory Networks in Breast Cancer Subtypes
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 26
Issue 24
10.3390/ijms262411832
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Retraction of Int. J. Mol. Sci. 2020, 21(1), 312.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Retraction

RETRACTED: Molagoda et al. GSK-3β-Targeting Fisetin Promotes Melanogenesis in B16F10 Melanoma Cells and Zebrafish Larvae through β-Catenin Activation. Int. J. Mol. Sci. 2020, 21, 312

by
Ilandarage Menu Neelaka Molagoda
1,
Wisurumuni Arachchilage Hasitha Maduranga Karunarathne
1,
Sang Rul Park
1,
Yung Hyun Choi
2,
Eui Kyun Park
3,
Cheng-Yun Jin
4,
Haiyang Yu
5,
Wol Soon Jo
6,
Kyoung Tae Lee
7 and
Gi-Young Kim
1,*
1
Department of Marine Life Sciences, Jeju National University, Jeju 63243, Republic of Korea
2
Department of Biochemistry, College of Oriental Medicine, Dong-Eui University, Busan 47227, Republic of Korea
3
Department of Oral Pathology and Regenerative Medicine, School of Dentistry, Institute for Hard Tissue and Biotooth Regeneration, Kyungpook National University, Daegu 41940, Republic of Korea
4
School of Pharmaceutical Science, Institute of Drug Discovery and Development, Zhengzhou University, Zhengzhou 450001, China
5
Institute of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China
6
Department of Research Center, Dong Nam Institute of Radiological and Medical Sciences, Busan 619953, Republic of Korea
7
Forest Biomaterials Research Center, National Institute of Forest Science, Jinju 52817, Republic of Korea
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2025, 26(24), 11832; https://doi.org/10.3390/ijms262411832
Submission received: 2 December 2025 / Accepted: 6 December 2025 / Published: 8 December 2025
(This article belongs to the Section Bioactives and Nutraceuticals)
Versions Notes
The journal retracts the article, “GSK-3β-Targeting Fisetin Promotes Melanogenesis in B16F10 Melanoma Cells and Zebrafish Larvae through β-Catenin Activation” [1], cited above.
Following publication, concerns were brought to the attention of the Editorial Office regarding potential irregularities found in images presented in this article [1].
Adhering to our standard procedure, an investigation was conducted by the Editorial Office and Editorial Board, which confirmed multiple panel overlaps contained within Figure 2, presenting different experimental conditions. While the authors collaborated within this process, supporting material and explanations provided did not meet Editorial Board expectations in order to resolve the issues raised. As a result, the Editorial Board has lost confidence in the reliability of the findings and decided to retract this publication [1], as per MDPI’s retraction policy (https://www.mdpi.com/ethics#_bookmark30).
This retraction was approved by the Editor-in-Chief of IJMS journal.
The authors did not provide a comment on this decision.

Reference

  1. Molagoda, I.M.N.; Karunarathne, W.A.H.M.; Park, S.R.; Choi, Y.H.; Park, E.K.; Jin, C.-Y.; Yu, H.; Jo, W.S.; Lee, K.T.; Kim, G.-Y. RETRACTED: GSK-3β-Targeting Fisetin Promotes Melanogenesis in B16F10 Melanoma Cells and Zebrafish Larvae through β-Catenin Activation. Int. J. Mol. Sci. 2020, 21, 312. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Molagoda, I.M.N.; Karunarathne, W.A.H.M.; Park, S.R.; Choi, Y.H.; Park, E.K.; Jin, C.-Y.; Yu, H.; Jo, W.S.; Lee, K.T.; Kim, G.-Y. RETRACTED: Molagoda et al. GSK-3β-Targeting Fisetin Promotes Melanogenesis in B16F10 Melanoma Cells and Zebrafish Larvae through β-Catenin Activation. Int. J. Mol. Sci. 2020, 21, 312. Int. J. Mol. Sci. 2025, 26, 11832. https://doi.org/10.3390/ijms262411832

AMA Style

Molagoda IMN, Karunarathne WAHM, Park SR, Choi YH, Park EK, Jin C-Y, Yu H, Jo WS, Lee KT, Kim G-Y. RETRACTED: Molagoda et al. GSK-3β-Targeting Fisetin Promotes Melanogenesis in B16F10 Melanoma Cells and Zebrafish Larvae through β-Catenin Activation. Int. J. Mol. Sci. 2020, 21, 312. International Journal of Molecular Sciences. 2025; 26(24):11832. https://doi.org/10.3390/ijms262411832

Chicago/Turabian Style

Molagoda, Ilandarage Menu Neelaka, Wisurumuni Arachchilage Hasitha Maduranga Karunarathne, Sang Rul Park, Yung Hyun Choi, Eui Kyun Park, Cheng-Yun Jin, Haiyang Yu, Wol Soon Jo, Kyoung Tae Lee, and Gi-Young Kim. 2025. "RETRACTED: Molagoda et al. GSK-3β-Targeting Fisetin Promotes Melanogenesis in B16F10 Melanoma Cells and Zebrafish Larvae through β-Catenin Activation. Int. J. Mol. Sci. 2020, 21, 312" International Journal of Molecular Sciences 26, no. 24: 11832. https://doi.org/10.3390/ijms262411832

APA Style

Molagoda, I. M. N., Karunarathne, W. A. H. M., Park, S. R., Choi, Y. H., Park, E. K., Jin, C.-Y., Yu, H., Jo, W. S., Lee, K. T., & Kim, G.-Y. (2025). RETRACTED: Molagoda et al. GSK-3β-Targeting Fisetin Promotes Melanogenesis in B16F10 Melanoma Cells and Zebrafish Larvae through β-Catenin Activation. Int. J. Mol. Sci. 2020, 21, 312. International Journal of Molecular Sciences, 26(24), 11832. https://doi.org/10.3390/ijms262411832

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop